-
CVS Q2 profit jumps 23%
Woonsocket, R.I. -- CVS Caremark Corp.’s first-quarter earnings rose a better-than-expected 23% as new generic drugs and demand for flu medications helped the company’s profitability. The chain narrowed its 2013 guidance to reflect higher-than-expected performance.
For the first quarter, CVS earned $956 million, up from $776 million in last year's quarter.
Companywide revenue slipped 0.1% to $30.76 billion, but exceeded the $30.36 billion that Wall Street expected.